Exclusive: Prelude gets $5.5M to double workforce, expand labs
Share
WILMINGTON – Cancer research company Prelude Therapeutics recently secured $5.5 million in state taxpayer-backed grants to move to new, larger labs and more than double its workforce in the state. The recent infusion of state dollars, the third time that Delaware has doled out public funds to support the growth of the company, came just
Want to Read More?
Paid DBT subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ.
Already an Insider? Log In.